Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
Journal
The European respiratory journal
Journal Volume
59
Journal Issue
5
Date Issued
2022-05
Author(s)
Bateman, Eric D
Price, David B
Khattab, Adel
Schonffeldt, Patricia
Catanzariti, Angelina
van der Valk, Ralf J P
Beekman, Maarten J H I
Abstract
To gain a global perspective on short-acting β2-agonist (SABA) prescriptions and associated asthma-related clinical outcomes in patients with asthma, we assessed primary health data across 24 countries in five continents.
Type
journal article